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Abstract: Microarray data produced by microarray are useful for cancer classification. 
However, the process of gene selection for the classification faces with a major problem due 
to the properties of the data such as the small number of samples compared to the huge 
number of genes (higher-dimensional data), irrelevant genes, and noisy data. Hence, this 
paper proposes a three-stage gene selection method to select a smaller subset of informative 
genes that is most relevant for the cancer classification. It has three stages: I) pre-selecting 
genes using a filter method to produce a subset of genes; 2) optimising the gene subset using a 
multi-objective hybrid method to yield near-optimal subsets of genes; 3) analysing the 
frequency of appearance of each gene in the different near-optimal gene subsets to produce a 
smaller (final) subset of informative genes. Two microarray data sets are used to test the 
effectiveness of the proposed method. Experimental results show that the performance of the 
proposed method is superior to other experimental methods and related previous works. A list 
of informative genes in the final gene subset is also presented for biological usage. 
Keywords: Cancer Classification, Gene Selection, Genetic Algorithm, Hybrid Method, 
Three-Stage Method. 
1. INTRODUCTION 
Microarray technology is used to measure the expression levels of thousands of genes 
simultaneously, and finally produce microarray data. A comparison between the gene 
expression levels of cancerous and normal tissues can also be done. This comparison is useful 
to select those genes that might anticipate the clinical behaviour of cancers. Thus, there is a 
e of the followirq 
d to the small m 
To overcome the 
. works have usel 
. Thus, d 
.genes (mini 
accuracy (It 
S is evalUlle 
Jilid 20, Bi!. 4 (Disember2008) Jumal TeknologiMaklumat 
33 
need to select informative genes that contribute to a cancerous state. An informative gene is 
useful for cancer classification. However, the gene selection process poses a major challenge 
because of the following characteristics of microarray data: the huge number of genes 
compared to the small number of samples (higher-dimensional data), irrelevant genes, and 
noisy data. 
To overcome the challenge, a gene selection method is used to select a subset of 
genes for cancer classification. The gene selection method has several advantages such as 
maintaining or improving classification accuracy, reducing the dimensionality of data, and 
removing irrelevant and noisy genes. 
There are two types of gene selection methods [10]: if a gene selection method is 
carried out independently from a classifier, it belongs to the filter approach; otherwise; it is 
said to follow a hybrid (wrapper) approach. In the early era of microarray analysis, most 
previous works have used the filter approach to select genes because it is computationally 
more efficient than the hybrid approach [1],[4],[11]. However, the filter approach results in 
inclusion of irrelevant and noisy genes in a gene subset for the cancer classification. The 
hybrid approach usually provides greater accuracy than the filter approach. Until now, several 
hybrid methods, especially a combination between a genetic algorithm (GA) and a support 
vector machine (SYM) classifier (GASVM), have been implemented to select informative 
genes [2],[3],[5-8],[10]. The drawbacks of the hybrid methods (GASYM-based methods) in 
the previous works are [2],[3],[5-8],[10]: 1) intractable to efficiently produce a smaller subset 
of informative genes when the total number of genes is too large (higher-dimensional data); 
2) the high risk of over-fitting problems. 
In order to solve the problems derived from microarray data and overcome the 
limitation of the hybrid methods in the previous works [2],[3],[5-8],[10], we propose a three­
stage gene selection method (3-SGS). This proposed method is able to perform well in the 
higher-dimensional data and reduce the high risk of over-fitting problems since it has three 
stages as follows: stage 1 for producing a subset of genes; stage 2 for resulting near-optimal 
subsets of genes; stage 3 for yielding a smaller (final) subset of informative genes based on 
the frequency of appearance for each gene in the near-optimal subsets. The diagnostic goal is 
to develop a medical procedure based on the least number of possible genes that needed to 
detect diseases. Thus, the ultimate goal of this paper is to select a smaller subset of 
informative genes (minimise the number of selected genes) for yielding higher cancer 
classification accuracy (maximise the classification accuracy). To achieve the goal, we adopt 
3-SGS. 3-SGS is evaluated on two real microarray data sets of tumour samples. 
The outline of this paper is as follows: Sections 2 and 3 discuss previous works and 
the detail of the proposed three-stage method, respectively. In Section 4, microarray data sets 
Jilid20, Bil.4 (Disember 2008) JumalTeknologi Maklumat 
34 
used, experimental setup, and experimental results are described. The conclusion of this paper 
is provided in Section 5. 
2. PREVIOUS WORKS 
Several hybrid methods, i.e., GASVM-based methods have been proposed for genes selection 
of microarray data [2],[3],[5-8],[10]. The hybrid methods usually provide greater accuracy 
than filter methods since genes are selected by considering relations among genes. Generally, 
our previous GASVM-based methods performed well in higher-dimensional data, e.g., 
microarray data since we proposed a modified chromosome representation and a multi­
objective approach [5-7]. However, the methods yielded inconsistent results when they were 
run independently. 
The work of Huang and Chang can simultaneously optimise genes and SVM 
parameter settings by using a GASVM-based method (2). Next, integrated algorithms based 
on GASVM have been proposed by the works of Shah and Kusiak (10), and Lee (3) to 
produce a small subset of genes. Peng et al. introduced a recursive feature elimination post­
processing step after the step of a GASVM-based method in order to reduce the number of 
selected genes again (8). 
Nevertheless, the GASVM-based methods of the previous works are still intractable 
to efficiently produce a smaller subset of informative genes from higher-dimensional data due 
to their binary chromosome representation drawback [2],[3],[6-8],[10]. The total number of 
gene subsets produced by GASVM-based methods is calculated by Me = 2M -I where Me is 
the total number of gene subsets, whereas M is the total number of genes. Based on this 
equation, the GASVM-based methods are almost impossible to evaluate all possible subsets 
of selected genes if M is too many (higher-dimensional data). Although the work of Peng et 
al. have implemented a pre-processing step to decrease the dimensionality of data, but it can 
only reduce a small number of genes, and many genes are still available in the data [8]. The 
GASVM-based methods also face with the high risk of over-fitting problems. The over-fitting 
problem that occurred on hybrid methods (e.g., GASVM-based methods) was also reported in 
a review paper in Saeys et al. [9]. 
3. THE PROPOSED THREE-STAGE GENE SELECTION METHOD (3-SGS) 
In order to overcome the drawbacks of GASVM-based methods in the related 
previous works [2],[3],[5-8],[10], we propose a three-stage gene selection method (3­
SGS). 3-SGS in our work differs from the methods in the previous works in one major 
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Figure I. The proposed method (3-SGS). 
3.1 Stage 1: Pre-selecting Genes Using a Filter Method 
A filter method such as gain ratio (GR) or information gain (IG) is used to pre-select genes 
and finally produce a subset of genes. After the pre-select process, the dimensionality of data 
is also decreased. The filter method calculates and ranks a score for each gene. Genes with the 
highest scores are selected and put into a gene subset. This subset is then used as an input to 
the second stage. 
Since GASVM-based methods in previous works performs poorly in higher­
dimensional data, and meanwhile, we also use a GASVM-based method, i.e., a multi­
objective GASVM (MOGASVM) in the second stage of 3-SGS, a filter method (GR or IG) in 
this first stage is used to reduce the higher-dimensional in order to overcome the drawback of 
GASVM-based methods. If the subset that produced by the filter method is in small­
dimension, the combination of genes is not complex, and then MOGASVM can possible to 
produce near-optimal genes subsets. 
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part. The major difference is that our proposed method involves three stages, whereas 
the previous works usually used only one stage (using a hybrid method) [2],[3],[5­
7],[10] or two stages (using a filter method and a hybrid method) [8] for gene 
selection. In the third stage, our method implements frequency analysis to identify the 
most frequently selected genes in near-optimal gene subsets, whereas the previous 
works [2],[3],[5-8],[10] rely solely on a filter method or a hybrid method in the first 
stage of their methods. The difference is necessary in order to produce near-optimal 
gene subsets from higher-dimensional data, reduce the high risk of over-fitting 
problems, and finally yield a smaller subset of informative genes. 3-SGS is shown in 
Fig. I. The detailed stages are described as follows: 
Stage 3: Analysing the frequency of 
each gene in near-optimal subsets I , 
1~ .1 
r--------------------------------------­
1 1 
I 1 
I I 
I I 
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selection method 
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3.2 Stage 2: Optimising a Gene Subset Using MOGASVM 
In this stage, we develop MOGASVM to automatically optimise a gene subset that is 
produced by the first stage, and finally yield near-optimal subsets of genes. This stage is 
cycled until the maximum number of cycles is satisfied. The near-optimal subsets are 
identified by an evaluation function in MOGASVM that uses two criteria: maximisation of 
leave-one-out-cross-validation (LOOCV) accuracy and minimisation of the number of 
selected genes. MOGASVM selects and optimises genes by considering relations among 
them in order to remove irrelevant and noisy genes. The near-optimal subsets are possible to 
be found due to the dimensionality and complexity of data has been firstly reduced by the first 
stage. The high risk of over-fitting problems can be also decreased because of the reduction. 
The detail ofMOGASVM can be found in our previous work [7]. 
3.3 Stage 3: Analysing the Frequency of Each Gene in Near-optimal Subsets 
The frequency of appearance for each gene in each near-optimal gene subset is examined and 
analysed to assess the relative importance of genes for cancer classification. The most 
frequently selected genes in near-optimal gene subsets are presumed to be the most relevant 
for the classification. Finally, a smaller (final) subset of inforinative genes (K genes, K is a 
number of genes) is produced and used to construct an SVM classifier. This subset contains a 
smaller number of informative genes with higher classification accuracy. This paper has 
produced two methods of 3-SGS obtained from combinations of two different filter methods 
(GR and IG) and MOGASVM. These methods are 3-SGS-GR and 3-SGS-IG. 
4. EXPERIMENTS 
4.1 Data Sets and Experimental Setup 
Two benchmark microarray data sets that contain binary classes and multi-classes of cancer 
samples are used to evaluate 3-SGS. It is summarised in Table I. Table 2 contains parameter 
values for 3-SGS. These values are chosen based on the results of preliminary runs. Three 
criteria following their importance are considered to evaluate the performance of 3-SGS: test 
accuracy on the test set, LOOCV accuracy on the training set, and the number of selected 
genes. Higher accuracies and a smaller number of selected genes are needed to obtain an 
excellent performance. The top,'200 genes are pre-selected by using GR and IG in the first 
stage of the 3-SGS, and are then used for the second stage. 
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Table 1. The summary of micro array data sets. 
Number of classes Number ofsampJes in Number of samples Number Source 
the trainin set in the test set of enes 
3 (ALL, MLL, and 57 (20 ALL, 17MLL, 15 (4 ALL, 3 MLL, 12,582 http://www.broad.mit.edu/ 
AML) and 20 AML) and 8 AML) cgi-bin/cancer/datasets.cgi 
2 (Normal and 62 (22 normal and 40 Not available 2,000 http.z/microarray.princeto 
tumour) tumour) n.edu/oncology/affydata/i 
ndex.html 
Note: 
ALL=acute lymphoblastic leukaemia. AML = acute myeloid leukaemia. 
LL= mixed-lineage leukaemia. 
Table 2. Parameter settings for 3-SGS. 
Parameters MLL data set Colon data set 
Size of population 100 100 
Number of generation 300 300 
Crossover rate 0.7 0.7 
Mutation rate 0.01 0.01 
Maximum number of cycles 10 10 
Cost for an SYM classifier 100 100 
4.1 Experimental Results 
4.1.1 Classification accuracies of final informative genes 
As shown in Fig. 2, the best results of the MLL (100% LOOCY and 100% test accuracies), 
and the colon data sets (96.77% LOOCY) are obtained by using the only six (using 3-S0S­
OR) and 20 (using 3-SGS-GR) final selected informative genes (K genes), respectively. 
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The numbel of final selected Informative genes The number of final eerect ed Informative genes 
(a) 3-SGS-GR on the MIL data set (b) 3-SGS-IG on the MIL data set 
llD~K:f~~......::::.....~_:r~ ........=....
 
The number of flnel K~d Infonnlltive gene. The number (If final selected Informative genes 
(c) 3-SGS-GR on the colon data set (d) 3-SGS-IG on the colon data set 
Figure 2. A relation between classification accuracies and the number of final selected 
informative genes (K genes) using 3-SGS. 
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Table 3. The list of informative genes in the final gene subsets. 
RankData Set Gene IDScore 
MLL 
9 
7 
3 
3 
2 
2 
MlI722 
M13143 
U41843 
Z83844 
L08895 
U59878 
8 R62945 
8 T51261 
7 T52003 
6 T62947 
5 
5 
5 
R54097 
030755 
R38513 
4 H42477 
Colon 
4 
4 
RI5447 
U29l71 
4 R49459 
4 H87135 
4 M76378 
4 102854 
3 
3 
3 
3 
3 
3 
U07695 
T47377 
Z11502 
M63391 
H82719 
H72110 
Gene Description 
human terminal transferase mRNA, complete cds 
nucleotide sequence of the eDNA insert of lambda 
human Dr l-associated corepressor (DRAP I) mRNA 
vicpro2.D07.r Homo sapiens eDNA, 5' end 
homo sapiens MADS 
human low-Mr GTP-binding protein (RAB32) mRNA 
COMPLEMENT DECAY-ACCELERATING 
FACTOR I PRECURSOR (Homo sapiens) 
GLIA DERIVED NEXIN PRECURSOR (Mus 
musculus) 
CCAA T/ENHANCER BINDING PROTEIN ALPHA 
(Rattus norvegicus) 
60S RIBOSOMAL PROTEIN L24 (Arabidopsis 
thaliana) 
TRANSLATIONAL INITIAnON FACTOR 2 BETA 
SUBUNIT (HUMAN);. 
Human mRNA (HA1652) for ORF, partial cds. 
FIBROBLAST GROWTH FACTOR RECEPTOR 2 
PRECURSOR (Homo sapiens) 
RAS-RELATED C3 BOTULINUM TOXIN 
SUBSTRATE I (Homo sapiens) 
CALNEXIN PRECURSOR (Homo sapiens) 
Human casein kinase I delta mRNA, complete cds. 
TRANSFERRIN RECEPTOR PROTEIN (Homo 
sapiens) 
IMMEDIATE-EARLY PROTEIN IE 180 (Pseudorabies 
virus) 
Human cysteine-rich protein (CRP) gene, exons 5 and 
6.
 
MYOSIN REGULATORY LIGHT CHAIN 2,
 
SMOOTH MUSCLE ISOFORM (HUMAN);contains
 
element TAR I repetitive element;.
 
Human tyrosine kinase (HTK) mRNA, complete cds.
 
S-IOOPPROTEIN (HUMAN).
 
H.sapiens mRNA for intestine-specific annexin.
 
Human desmin gene, complete cds
 
BETA-ADAPTIN (Homo sapiens)
 
T-CELL RECEPTOR BETA CHAIN PRECURSOR
 
(Oryctolagus cuniculus)
 
Many runs have achieved 100% LOOCV accuracy especially on the MLL the data 
sets. This has proved that 3-SGS has efficiently selected and produced a smaller subset of 
informative genes from a solution space. This is due to the fact that a filter method in the first 
stage of 3-SGS reduces the dimensionality of the solution space in order to produce a gene 
subset. Next, MOGASVM in the second stage of 3-SGS optimise the subset automatically to 
yield near-optimal subsets of genes. These subsets are obtained since MOGASVM in 3-SGS 
considers and optimise: 
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considers and optimises a relation among genes. Finally, the first K genes appearing most 
frequently are selected as the final selected informative genes for cancer classification. 
4.1.2 A list of informative genes for biological usage 
The informative genes and their rank scores (frequency) of the final subsets as produced by 
the proposed 3-SGS and reported in Fig. 2 are listed in Table 3. These informative genes 
among the thousand of genes may be the excellent candidates for clinical and medical 
investigations. Biologists can save much time since they can directly refer to the genes that 
have higher possibility to be useful for cancer diagnosis and drug target in the future. 
4.1.3 3-SGS versus other previous methods 
Table 4 displays the benchmark of this work and previous related works that used filter and 
hybrid approaches. Overall, 3-SGS in this work has outperformed the previous works on 
MLL the data set in terms of the test accuracy, the LOOCV accuracy, and the number of 
selected genes. For the colon data set, the average cross-validation result produced by 
Mohamad et ai. [6] was slightly higher than our work. Our work only unclassified two 
samples to finally yield 96.77% LOOCV accuracy. However, an objective comparison could 
not be done because his work only used one benchmark microarray data set. 
Generally, filter methods in previous works [I ],[4],[II] achieved poor performances 
since they may result in inclusion of irrelevant and noisy genes in a gene subset for the cancer 
classification. This situation is happen because the methods evaluate a gene based on its 
discriminative power for the target classes without considering its relations with other genes. 
GASVM-based methods [2],[3],[5-8],[10] may be unable to produce a smaller subset 
of informative genes because they perform poorly in higher-dimensional data due to their 
chromosome representation drawback. GASVM-II [5] method is impractical to be used in real 
applications because a variety number of selected genes should be tested in order to obtain the 
near-optimal one. On the contrary, the proposed 3-SGS that pre-selects a number of genes at 
the first stage can reduce the data dimensionality and produce a gene subset. This subset is 
then optimised by MOGASVM in the second stage of 3-SGS to yield near-optimal subsets. 
Finally, the first K genes appearing most frequently are selected as the final selected 
informative genes (a smaller subset) for cancer classification. 
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Table 4. The benchmark of 3-SGS with previous methods on the MLL and colon data sets. 
plexity of solutj 
. matical1y optim 
Gene Selection Method (Category) 
[Reference] 
MLL Data Set 
#Selected Accuracy (%) 
Genes CV Test 
Colon Data Set 
#Selected CV Accuracy 
Genes (%) 
.gene subsets. Fi 
.-.elected informativ 
i<', 
3-SGS (Filter, hybrid, and frequency 
analysis) 6 100 100 20 96.77 
GASVM (Hybrid) [2] 
GASVM (Filter and hybrid) [8] 
(3.5) (100) 
12 93.55 
of the large m: 
F-test and Cho's method (Filter) [II] 23 97.2 .er, due to the apl 
Principal component analysis (Filter) [I] 100 95 d genes is di 
Information gain (Filter) [4] 100 with higher ace 
An integrated algorithm (Hybrid) [3] (99.13) 
, a combinati 
GAS VM-II+GASVM (Hybrid) [6] (6.5) (100) (92) (11.6) (99.52) 
GASVM-II (Hybrid) [5] (30) (100) (84.67) (30) (99.03) 
MOGASVM (Hybrid) [7] (4,465.2) (94.74) (90) (446.3) (93.23) 
GASVM (Hybrid) [5] (6,298.8) (94.74) (87.33) (979.8) (91.77) 
Note: The results of the best subsets shown in shaded cells. '-' means that a result is not reported in the related previous 
work. A result in '( )' denotes an average result. CV and #Selected Genes represent cross-validation and a number of 
selected genes, respectively. Methods in italics style are experimented in this work. 
The gap between LOOCV accuracy and test accuracy that resulted by 3-SGS was also 
lower. This small gap shows that the risk of the over-fitting problem can be reduced. On the 
other hand, the results of LOOCV accuracy of the related previous works were much higher 
than their test accuracy because they were unable to avoid or reduce the risk of over-fitting 
problems. Other previous works that used GASVM-based methods [2],[8] did not provide any 
test accuracy results and thus, the over-fitting problem could not be investigated in their 
works. Over-fitting is a major problem on hybrid methods in gene selection and classification 
of microarray data when the classification accuracy on training samples, e.g., LOOCV 
accuracy is much higher than the test accuracy. This is also supported by a review paper in 
Saeys et al. [9] which reported that hybrid methods (e.g., GASVM-based methods) confront 
with the high risk of over-fitting problems because ofthe higher-dimensional data. 
5. CONCLUSIONS 
In this paper, a three-stage gene selection method (3-SGS) has been proposed and tested for 
gene selection on two microarray data sets that contain binary classes and multi-classes of 
tumour samples. Based on the experimental results, the performance of3-SGS was superior to 
other methods in related previous works. This is due to the fact that the filter method in the 
first stage of the 3-SGS can pre-select genes and reduce dimensionality of data in order to 
produce a subset of genes. When the dimensionality was reduced, the combination of genes 
4 (Disember 
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and complexity of solution spaces were automatical1y decreased. The second stage of 3-SGS 
can automatical1y optimise the subset that is yielded by the first stage in order produce near­
optimal gene subsets. Final1y, the first K genes appearing most frequently are selected as the 
final selected informative genes (a smal1er subset) for cancer classification. Hence, the gene 
selection using 3-SGS is needed to produce a smal1er subset of informative genes for better 
cancer classification of microarray data. 3-SGS in this paper also obtains short running time 
because of the large number of genes are removed by a filter technique in the first step. 
However, due to the application of a filter method in the first stage of 3-SGS, the number of 
pre-selected genes is difficult since it is manual1y done. Even though 3-SGS has classified 
tumours with higher accuracy, it is still not able to completely avoid the over-fitting problem. 
Therefore, a combination between a statistical approach and a hybrid method will be 
proposed to solve the problem. 
ACKNOWLEDGEMENTS 
This study was supported and approved by Universiti Teknologi Malaysia, Osaka Prefecture 
University, and Malaysian Ministry of Higher Education. The authors grateful1y thank the 
referees for the helpful suggestions. 
REFERENCES 
[I]	 Armstrong, S. A., Staunton, 1. E., Silverman, L. 8., Pieters, R., Boer, M. L., Minden, M. 
D., Sal1an, S. E., Lander, E. S., Golub, T. R. and Korsmeyer, S. J., "MLL trans locations 
specify a distinct gene expression profile that distinguishes a unique leukemia", Nature 
Genetics, Volume 30, ppAI-47, 2002. 
[2] Huang,	 H. L. and Chang, F. L., "ESVM: Evolutionary support vector machine for 
automatic feature selection and classification of microarray data", BioSystems, Volume 
90, pp.516-528, 2007. 
[3] Lee,	 Z. 1. "An integrated algorithm for gene selection and classification applied to 
microarray data of ovarian cancer", Artificial Intel1igence in Medicine, Volume 42, 
pp.81-93,2008. 
[4] Li, J., Liu, H., Ng, S. K. and Wong, L., "Discovery	 of significant rules for classifying 
cancer diagnosis data", Bioinformatics, Volume 19, pp.93-102, 2003. 
[5] Mohamad, M. S., Deris, S. and Illias, R. M., "A hybrid of genetic algorithm and support 
vector machine for features selection and classification of gene expression microarray", 
International Journal of Computational Intelligence and Applications, Volume 5, pp.91­
107,2005. 
Iilid 20, Bil. 4 (Disember2008)	 Iumal Teknologi Maklumat 
42 
[6] Mohamad, M. S., Omatu, S., Deris, S., Misman, M. F. and Yoshioka, M., "Selecting PRO] 
informative genes from microarray data by using hybrid methods for cancer CONSTRl 
classification", International Journal of Artificial Life & Robotics, Volume 13, Issue 2, 
2008. 
[7] Mohamad, M. S., Omatu, S., Deris, S., Misman, M. F. and Yoshioka, M., "A multi­ cacul~ 
objective strategy in genetic algorithm for gene selection of gene expression data", 
International Journal of Artificial Life & Robotics, Volume 13, Issue 2, 2008. 
[8] Peng, S., Xu, Q., Ling, X. B., Peng, X., Du, W. and Chen, L., "Molecular classification of 
cancer types from microarray data using the combination of genetic algorithms and 
support vector machines", FEBS Letters, Volume 555, pp.358-362, 2003. 
[9] Saeys, Y'; Inza, 1. and Larranaga, P., "A review of feature selection techniques in 
bioinformatics", Bioinformatics, Volume 23, Issue 19, pp.2507-25 17, 2007. 
[10] Shah, S. and Kusiak, A., "Cancer gene search with data-mining and genetic 
algorithms", Computers in Biology & Medicine, Volume 37, Issue 2, pp.251-26I, 2007. 
(II] Yang, K., Cai, Z., Li, J. and Lin, G., "A stable gene selection in microarray data 
analysis", BMC Bioinformatics, Volume 7, pp.228-246, 2006. 
Jilid 20, Bi\. 4 (Disember 2008) Jurnal Teknologi Maklumat 
D 
